| abstract |
The present invention relates to a serine protease having serine protease activity in the presence of a serine protease inhibitor in a subject treated with a serine protease inhibitor and capable of completely or partially reversing the serine protease inhibitor action. It relates to a recombinant protein comprising a polypeptide. More specifically, recombinant proteins and methods for completely or partially reversing the anticoagulant action of a coagulation inhibitor are described herein. |